Consolidated Financial Results
for the Fiscal Year Ended June 30, 2022
[Japanese GAAP]
August 9, 2022
Company name: OLBA HEALTHCARE HOLDINGS, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 2689
URL: https://www.olba.co.jp/
Representative: Yohei Maeshima, President CEO
Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department
Phone: +81-86-236-1115
Scheduled date of general meeting of shareholders: September 21, 2022
Scheduled date of commencing dividend payments: September 22, 2022
Scheduled date of filing securities report: September 22, 2022
Availability of supplementary briefing material on financial results: Unavailable
Schedule of financial results briefing session: Scheduled (for securities analysts)(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Fiscal Year Ended June 30, 2022 (July 1, 2021 to June 30, 2022)(1) Consolidated Operating Results(% indicates changes from the previous year.)
Net income
Net sales
Operating income
Ordinary income
attributable toowners of parent
Fiscal year ended
Million yen%
Million yen%
Million yen%
Million yen%
107,959
5.8
2,073
34.6
2,119
37.4
1,535
55.2
June 30, 2022
102,072
–
1,540
66.2
1,542
70.3
989
203.1
June 30, 2021
(Note) Comprehensive income: Fiscal year ended June 30, 2022: ¥1,432 million [26.9 %]Fiscal year ended June 30, 2021: ¥1,128 million [314.1 %]Basic earnings
per share

Diluted earnings
per share

Return on equity

Ratio of ordinary
income to total
assetsRatio ofoperating income
to net sales

Fiscal year ended
Yen
Yen
%
%
%
252.80
–
17.8
5.5
1.9
June 30, 2022
162.66
–
12.8
4.4
1.5
June 30, 2021
(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the
Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and otherstandards. In accordance with the principle-based treatment of the standards, the consolidated operating
results for the fiscal year ended June 30, 2021 have been restated retroactively. The change in net sales forthe fiscal year ended June 30, 2021 are, therefore, not presented.
(2) Consolidated Financial Position
Total assets

Net assets

Million yen

39,968
As of June 30, 2022
36,562As of June 30, 2021
(Reference) Equity: As of June 30, 2022: ¥9,093 million
As of June 30, 2021: ¥8,131 million

Net assets per share

Equity ratio

Million yen

%

Yen

9,093
8,131

22.8
22.2

1,513.91
1,336.91

Cash flows fromfinancing activities

Cash and cash
equivalents at endof period(3) Consolidated Cash Flows
Cash flows fromoperating activities
As of June 30, 2022
As of June 30, 2021

Cash flows frominvesting activities

Million yen

Million yen

Million yen

Million yen

2,420
3,126

(211)
(630)

(1,169)(2,262)

3,149
2,110

2. Dividends
Annual dividends
1st
2nd
3rd
quarter-end quarter-end quarter-end Year-end
Fiscal year ended
June 30, 2021
Fiscal year ended
June 30, 2022
Fiscal year ending
June 30, 2023
(Forecast)Total
annualdividends

Total

Payout
ratio
%

%

309

30.7

3.9

367

23.7

4.2

Yen Million yen

Yen

Yen

Yen

Yen

–

0.00

–

50.00

50.00

–

0.00

–

60.00

60.00

–

0.00

–

60.00

60.00

Ratio ofdividends toshareholders’equity–3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2023 (July 1, 2022 to June 30, 2023)(% indicates changes from the previous corresponding period.)
Net sales
Million yen

First half
Full year%

53,980 1.8
109,479 1.4

Operating income

Ordinary income

Million yen

Million yen%

753 (4.2)
2,000 (3.5)

Net income
attributable toowners of parent%

Yen

486 (8.7)
1,309 (14.7)

80.01
215.27% Million yen

753 (6.2)
1,998 (5.7)

Basic earnings
per share

Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): Yes
Newly consolidated: One (1) (Company Name: Kawanishi BarcMed Co.,Ltd);
Removed from consolidation: None (Company Name: –)(2) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: Yes
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None
(3) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
June 30, 2022: 6,250,000 shares
June 30, 2021: 6,250,000 shares2) Total number of treasury stock at the end of the period:
June 30, 2022: 243,515 shares
June 30, 2021: 167,676 shares
3) Average number of shares during the period:
Fiscal year ended June 30, 2022: 6,073,244 sharesFiscal year ended June 30, 2021: 6,082,368 shares
As of the end of the consolidated fiscal year ended June 30, 2022, 112,400 shares of the Company’s stock held by
the Board Benefit Trust were included in treasury stock.

(Reference) Summary of non-consolidated financial results
Non-consolidated Financial Results for the Fiscal Year Ended June 30, 2022 (July 1, 2021 to June 30, 2022)(1) Non-consolidated Operating Results(% indicates changes from the previous corresponding period.)
Net sales
Operating income
Ordinary income
Net income
Fiscal year ended
Million yen%
Million yen%
Million yen%
Million yen%
June 30, 2022
2,183
30.7
1,022
111.1
1,019
113.9
998 159.9
6.2
4.0
476
99.7
384
–
June 30, 2021
1,670
484
Basic earnings
per share

Fiscal year ended
June 30, 2022
June 30, 2021

Dilutedearnings
Yen

Yen

–
–

164.4663.17(2) Non-consolidated Financial Position
Total assets

Net assets

Million yen

As of June 30, 2022
8,937
As of June 30, 2021
7,838
(Reference) Equity: As of June 30, 2022: ¥4,658 million
As of June 30, 2021: ¥4,099 million

Equity ratio

Net assets per share

Million yen

%

Yen

4,658
4,099

52.1
52.3

775.62673.94* These financial results are outside the scope of audit procedures conducted by a certified public accountant or audit
corporation.
* Explanation of the proper use of financial results forecast and other notes• The figures forecasted above were prepared based on information that is available as of the date of
publication of this document. Actual results may differ from these forecast figures due to various factors
in the future.

2. Consolidated Financial Statements and Principal Notes(1) Consolidated Balance Sheets(Thousand yen)
As of June 30, 2021
AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade
Notes and accounts receivable - trade, and contract assets
Electronically recorded monetary claims - operating
Merchandise
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant and equipment
Buildings and structures
Accumulated depreciation
Buildings and structures, net
Machinery, equipment and vehicles
Accumulated depreciation
Machinery, equipment and vehicles, net
Tools, furniture and fixtures
Accumulated depreciation
Tools, furniture and fixtures, net
Land
Leased assets
Accumulated depreciation
Leased assets, net
Construction in progress
Total property, plant and equipment
Intangible assets
Goodwill
Other
Total intangible assets
Investments and other assets
Investment securities
Retirement benefit asset
Deferred tax assets
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

As of June 30, 2022

2,158,875
18,719,596−
2,247,595
5,431,149
557,800(10,025)
29,104,992

3,189,805−
21,023,400
2,558,742
5,590,095
556,063(9,898)32,908,208

2,859,835(1,478,164)
1,381,670
108,483(69,631)38,852
1,169,110(1,009,674)
159,436
1,726,505
1,476,291(400,975)
1,075,315
271,800
4,653,580

2,928,309(1,328,837)
1,599,471
108,483(74,215)
34,267
1,177,227(990,794)
186,432
1,554,139
1,492,686(562,943)
929,743379
4,304,433−
698,501
698,501

22,997
791,977
814,974

237,6081,089,390
294,734
842,383(359,124)
2,104,991
7,457,073
36,562,066

223,803992,218
342,456
386,388(3,812)
1,941,055
7,060,464
39,968,672

(Thousand yen)
As of June 30, 2021
Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating
Short-term borrowings
Current portion of long-term borrowings
Lease liabilities
Income taxes payable
Provision for bonuses
Other
Total current liabilities
Non-current liabilities
Long-term borrowings
Lease liabilities
Deferred tax liabilities
Provision for share awards for directors (and other officers)
Retirement benefit liability
Long-term accounts payable - other
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders’ equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders’ equity
Accumulated other comprehensive income
Valuation difference on available-for-sale securities
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

As of June 30, 2022

16,304,571
6,824,412
300,000
220,000
169,290
524,874
35,2901,740,260
26,118,699

18,170,804
7,856,732−
220,000
154,154602,342
35,391
1,826,681
28,866,106

275,000
996,155
187,507
155,222398,652
279,927
19,3772,311,843
28,430,543

55,000855,227
113,725
212,628435,912278,127
58,6372,009,258
30,875,365

607,750
346,954
7,143,982(246,635)
7,852,050

607,750
315,704
8,369,369(375,903)
8,916,919

134,964
144,507279,472−
8,131,522
36,562,066

121,157
55,229176,387−
9,093,306
39,968,672

(2) Consolidated Statements of Income and Comprehensive Income
Consolidated Statements of Income

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Remuneration for directors (and other officers)
Salaries and allowances
Bonuses
Retirement benefit expenses
Provision for share awards for directors (and other officers)
Provision of allowance for doubtful accounts
Other
Total selling, general and administrative expenses
Operating profit
Non-operating income
Interest income
Dividend income
Insurance claim income
Electricity sale income
Commission income
Share of profit of entities accounted for using equity method
Other
Total non-operating income
Non-operating expenses
Interest expenses
Share of loss of entities accounted for using equity method
Electricity sale expenses
Consumption tax loss
Other
Total non-operating expenses
Ordinary profit

For the year ended
June 30, 2021
102,072,033
90,472,626
11,599,407(Thousand yen)
For the year ended
June 30, 2022
107,959,426
95,455,447
12,503,978389,208
4,571,975
1,098,991
223,554
61,316(1,968)3,715,567
10,058,645
1,540,761

388,386
4,659,355
1,221,101
199,303
65,168604
3,896,913
10,430,832
2,073,146

401
1,869
2,083
10,15929,394−
14,937
58,844

315
1,882
8,306
9,400
21,07026,776
11,986
79,73722,09718,319
6,149
5,825
4,889
57,281
1,542,325

20,519
−
5,631
−
6,888
33,0392,119,844

For the year ended
June 30, 2021
Extraordinary income
Gain on sale of property, plant and equipment
Subsidy income
Gain on step acquisitions
Total extraordinary income
Extraordinary losses
Loss on valuation of investment securities
Loss on sale of property, plant and equipment
Loss on retirement of property, plant and equipment
Loss on retirement of intangible
Impairment losses
Loss on tax purpose reduction entry of non-current assets
Total extraordinary losses
Profit before income taxes
Income taxes - current
Income taxes - deferred
Total income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent(Thousand yen)
For the year ended
June 30, 2022

1,419
−
−
1,419

29,930102,465
13,798146,195

28,440
−
824
1,076
−
−
30,341
1,513,403
627,610(103,575)
524,035
989,368−
989,368

1,265
2,915
3,802
−
18,770102,465
129,218
2,136,821
667,077(65,589)
601,487
1,535,333−
1,535,333

Consolidated Statements of Comprehensive Income

ProfitOther comprehensive income
Valuation difference on available-for-sale securities
Remeasurements of defined benefit plans, net of tax
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners of parent
Comprehensive income attributable to non-controllinginterests

For the year ended
June 30, 2021
989,368(Thousand yen)
For the year ended
June 30, 2022
1,535,333

14,044
125,500
139,544
1,128,913(13,807)(89,278)(103,085)
1,432,248

1,128,913−

1,432,248−

(3) Consolidated Statements of Changes in Equity
Year ended June 30, 2021 (from July 1, 2020 to June 30, 2021)(Thousand yen)
Shareholders’ equity

Balance at beginning of period
Changes during period
Dividends of surplus
Profit attributable to owners ofparentPurchase of treasury shares
Purchase of shares of consolidated
subsidiaries
Disposal of Treasury stock byownership plan trust
Net changes in items other thanshareholders’ equity
Total changes during period
Balance at end of period

Share capital

Capital surplus

607,750

346,954

Retainedearnings

6,433,568

Total
shareholders’equity(246,526)

7,141,746(278,954)(278,954)

989,368

989,368
(109)

(109)
−
−

−
607,750−
346,954

710,413
7,143,982

Accumulated other comprehensive income
Total accumulated
Valuation difference Remeasurementsotheron available-for-sale of defined benefit
comprehensive
securities
plans
incomeBalance at beginning of period
Changes during period
Dividends of surplus
Profit attributable to owners ofparentPurchase of treasury shares
Purchase of shares of consolidated
subsidiaries
Disposal of Treasury stock byownership plan trust
Net changes in items other thanshareholders’ equity
Total changes during period
Balance at end of period

Treasury shares

120,919

19,007

139,927(109)(246,635)

Non-controllinginterests−

710,3037,852,050

Total net assets

7,281,674(278,954)
989,368(109)−−

14,044

125,500

139,544−

139,544

14,044
134,964

125,500
144,507

139,544
279,472−−

849,848
8,131,522

Year ended June 30, 2022 (from July 1, 2021 to June 30, 2022)(Thousand yen)
Shareholders’ equity

Balance at beginning of period
Changes during period
Dividends of surplus
Profit attributable to owners ofparentPurchase of treasury shares
Purchase of shares of consolidated
subsidiaries
Disposal of Treasury stock byownership plan trust
Net changes in items other thanshareholders’ equity
Total changes during period
Balance at end of period

Share capital

Capital surplus

607,750

346,954

Retainedearnings

7,143,982

Total
shareholders’equity(246,635)

7,852,050(309,946)(309,946)

1,535,333

1,535,333(135,748)(31,250)−
607,750(31,250)
315,704

134,964

144,507(135,748)(31,250)

1,225,387
8,369,369

Accumulated other comprehensive income
Total accumulated
Valuation difference Remeasurementsotheron available-for-sale of defined benefit
comprehensive
securities
plans
incomeBalance at beginning of period
Changes during period
Dividends of surplus
Profit attributable to owners ofparentPurchase of treasury shares
Purchase of shares of consolidated
subsidiaries
Disposal of Treasury stock byownership plan trust
Net changes in items other thanshareholders’ equity
Total changes during period
Balance at end of period

Treasury shares

279,472

6,480

6,480

(129,268)(375,903)

1,064,869
8,916,919

Non-controllinginterests−

Total net assets

8,131,522(309,946)
1,535,333(135,748)(31,250)
6,480(13,807)(89,278)(103,085)−(103,085)(13,807)
121,157(89,278)
55,229(103,085)
176,387−−

961,783
9,093,306

(4) Consolidated Statements of Cash Flows

For the year ended
June 30, 2021
Cash flows from operating activities
Profit before income taxes
Depreciation
Impairment losses
Loss on tax purpose reduction entry of non-current assets
Increase (decrease) in allowance for doubtful accounts
Increase (decrease) in provision for bonuses
Decrease (increase) in retirement benefit asset
Increase (decrease) in retirement benefit liability
Increase (decrease) in provision for share awards for
directors (and other officers)
Loss (gain) on step acquisitions
Interest and dividend income
Subsidy income
Interest expenses
Loss (gain) on valuation of investment securities
Share of loss (profit) of entities accounted for using
equity method
Gain on sales of property, plant and equipment
Loss on sale of tangible fixed assets
Loss on retirement of property, plant and equipment
Loss on retirement of intangible assets
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Increase (decrease) in trade payables
Increase (decrease) in long-term accounts payable - other
Other, net
SubtotalInterest and dividends received
Interest paid
Subsidies received
Income taxes paid
Income taxes refund
Net cash provided by (used in) operating activities
Cash flows from investing activities
Proceeds from withdrawal of time deposits
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment
Purchase of intangible assets
Purchase of investment securities
Proceeds from purchase of shares of subsidiaries resulting
in change in scope of consolidation
Other, net
Net cash provided by (used in) investing activities(Thousand yen)
For the year ended
June 30, 2022

1,513,403
402,083−−(2,206)(1,255)(4,053)
21,85954,823

2,136,821
403,448
18,770102,465(1,608)100(31,518)
37,25957,405−(2,270)−22,09728,44018,319(13,798)(2,197)(102,465)
20,5191,265(26,776)(1,419)−824
1,076(1,921,289)(13,219)
3,193,235(30,016)
297,668
3,578,100
2,278(21,296)−(455,184)
22,4103,126,307(29,930)
2,915
3,802
−
(2,595,434)(158,945)
2,886,489(1,800)325,394
3,032,181
2,217(20,200)
102,465(725,441)
29,4202,420,642

500(379,230)
2,118(253,769)
−
−

8,000
(298,348)
227,789(155,008)(30,000)
35,7501(630,379)

10(211,806)

For the year ended
June 30, 2021
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
Repayments of long-term borrowings
Repayments of lease liabilities
Proceeds from sale and leaseback transactions
Purchase of treasury shares
Purchase of shares of subsidiaries not resulting
in change in scope of consolidation
Dividends paid
Other, net
Net cash provided by (used in) financing activities
Effect of exchange rate change on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period(Thousand yen)
For the year ended
June 30, 2022

(1,500,000)(320,000)(169,190)
5,984
(109)
−

(300,000)(220,000)(174,098)
1,738(135,748)(31,250)(278,680)(544)(2,262,540)−
233,387
1,877,288
2,110,675(310,547)−(1,169,906)−
1,038,929
2,110,675
3,149,605